• Title/Summary/Keyword: Nuclear medicine study

검색결과 2,892건 처리시간 0.035초

$^{99m}Tc-Methylene$ Diphosphonate의 연조직 섭취에 관한 연구 (Study on the Soft Tissue Uptake of $^{99m}Tc-Methylene$ Diphosphonate)

  • 범희승;박석건;정준기;이명철;조보연;고창순
    • 대한핵의학회지
    • /
    • 제20권1호
    • /
    • pp.17-24
    • /
    • 1986
  • Authors enumerate various malignant and benign cases which showed soft tissue uptake of $^{99m}Tc-MDP$. We hope it might be a help in understanding and interpreting bone scans. Among 10,361 $^{99m}Tc-MDP$ bone scans underwent from April, 1981 to March, 1986, 344 (3.3%) showed abnormal soft tissue uptake, which included 126 malignancies, 5 benign tumors, and 153 nontumorous diseases. Neuroblastoma(23.3%) and malignant fibrous histiocytoma(22.2%) showed highest positive uptake rate among various malignancies. We also illustrated typical cases according to possible mechanisms.

  • PDF

심근관류 SPECT에서 움직임 보정 방법들의 비교 (The Comparison of Motion Correction Methods in Myocardial Perfusion SPECT)

  • 박장원;남기표;이동훈;김성환
    • 핵의학기술
    • /
    • 제18권2호
    • /
    • pp.28-32
    • /
    • 2014
  • 심근 관류 SPECT 검사 중 환자의 움직임은 관류 결손과 인공물을 발생시켜 정확한 진단에 영향을 줄 수 있는 인자이다. 움직임으로 왜곡된 데이터를 보정하는 방법으로 움직임 보정방법이 개발되었고 각 방법마다 사용된 알고리즘이 다르기에 상황에 비교하고자 한다. 실험에 사용된 장비는 GE Ventri Gamma Camera와 Anthropomorphic Torso Phantom을 이용하였다. 팬텀을 환자 조건과 동일하게 하기 위하여 심근에 74 kBq/mL, 연부조직 1.1 kBq/mL, 폐 2.6 kBq/mL, 간 9.6 kBq/mL의 Tl-201을 주입하여 제작하고, 움직이는 상황에서 결손의 변화 관찰 목적으로 심근의 Anterior wall에 임의로 결손을 삽입하였다. 움직이지 않는 정상군과 일정간격(2 cm, 3 pixel) 상하 1회 이동, 상하 반복 이동, 좌우 1회 이동, 좌우 반복 이동한 데이터에 나누어 영상 획득하고 MDC, Hopkins, Stasis 방법을 적용하여 Polar map과 정량분석 Score로 비교 하였다. 환자와 동일한 조건으로 회전각 $6^{\circ}$, 50sec/frame으로 영상 획득하고, OSEM (2 iterations, 10 subsets), Butterworth filter (order 10; cutoff frequency; 0.32 cycle per pixel)를 적용, scatter correction, 감쇠보정은 적용하지 않았다. 팬텀 실험에서 세 가지 방법들에서 MDC 방법이 Visual 인공물 없이 잘 보정하였으나, 환자의 데이터에 이를 적용 하였을 때, 환자마다 움직임 보정방법 적용 결과들이 일정하지 않았다. 이는, 환자의 움직임이 일정하지 않고, 장기내의 동위원소의 비율도 다르기에 발생한다고 생각되며 추가적인 연구와 상황에 맞는 움직임 보정방법의 유동적인 사용이 필요하다고 사료된다.

  • PDF

핵의학과에서 환경방사선량 측정에 대한 연구 (A Study on the Environmental Radiation Dose Measurement in the Nuclear Medicine Department)

  • 강보선;임창선
    • 한국산학기술학회논문지
    • /
    • 제11권6호
    • /
    • pp.2118-2123
    • /
    • 2010
  • 국내의 경우 방사선작업종사자의 개인피폭관리는 선량한도를 초과한 피폭의 유무를 확인하여 사후 조치를 취하는 것에 초점이 맞추어져 있다. 그러나 의료기관 핵의학과의 경우 개봉선원을 사용하므로 작업환경이 방사선에 노출될 가능성이 많고, 방사성의약품 투여 후 수 시간 혹은 수 일 동안은 환자 자체가 방사선원이 되므로 방사선작업종사자나 수시출입자, 환자보호자들의 방사선 피폭 가능성이 매우 높다. 따라서 환자보호자 등 일반출입자의 방사선피폭을 방지하기 위해서는 환경방사선관리가 적절하게 실시되어야 한다. 일본에서는 "방사성동위원소등에 의한 방사선장해의 방지에 관한 법률" 등에 근거하여 방사선작업환경에 대한 환경방사선량을 정기적으로 측정, 보관하도록 하고 있다. 이에 대전시 소재 대학병원 핵의학과에서 일본에서 시행하고 있는 것과 같은 방법으로 핵의학과 내 8개소에 유리선량계를 설치하여 환경방사선을 측정한 결과 8개소 모두 "진단용 방사선 발생장치의 안전관리에 관한 규칙"에 규정된 방사선구역의 외부방사선량인 주당 0.3 mSv에는 훨씬 미치지 못하는 적은 선량이 측정되었다. 그러나 접수대에서는 3개월 누계 선량률이 0.51 mSv로서 접수대 종사자는 일반인 연간 유효선량한도인 1 mSv를 초과할 가능성이 높았으며, 환자 및 보호자 대기실에서도 0.23 mSv(3개월 누계치 0.69mSv)가 측정되어 유리선량계를 설치한 8개소 가운데 가장 높은 선량률을 보였다. 이것은 일반인의 연간 유효선량한도인 1 mSv를 초과하는 값이며, "방사선방호 등에 관한 기준 고시"에 환경상 위해방지를 위해 규정된 연간 유효선량 0.25 mSv를 초과하는 값이다. 따라서 접수대 근무자, 환자보호자 및 제3자 보호를 위해 핵의학과 내 환경방사선량 감소를 위한 적극적인 대책이 필요한 것으로 나타났다.

고용량 방사성옥소 치료의 기본 Protocol 비교 (Comparative Study for Basic Protocol of High Dose Ablation Therapy)

  • 문재승;정희일;이치영
    • 핵의학기술
    • /
    • 제12권3호
    • /
    • pp.147-156
    • /
    • 2008
  • 목적 : 방사성옥소 치료팀에서 이루어지고 있는 모든 행위가 나름대로의 원칙과 규정이 있으므로 단일화 된 모델은 적절한 최적화가 아닐 것으로 생각되나 통일성 있는 기준제시에 접근하고자 함이다. 실험재료 및 방법 : 2007년 11월 5일부터 11월 17일까지 29개 병원을 대상으로 핵의학 담당자에게 설문조사하였다. 설문조사의 내용은 환자에 대한 진료부문, 환자관리, 검사 부문, 폐기물관리, 안전관리 등 5개의 카테고리로 정하였으며 질문에 대한 응답내용을 선택하는 방식으로 조사하였다. 결과 : 2007년 10월 기준으로 전체 30개 병원에서 58개의 병실을 운영하고 있었으며 치료계획에 따른 검사 및 일정관리는 약간의 차이가 있었다. 환자에 대한 교육부문은 의사 및 간호사가 주로 담당하였으며 교육에 대한 환자의 만족도는 높은 것으로 평가되었다. 폐기물 관련 자료와 정기적으로 실시되고 있는 정기 감사로 인하여 각 병원별 폐기물 관리 수행은 원만히 이루어지고 있는 것으로 나타났다. 환자 및 작업종사자들에 대한 안전관리는 원자력법에 근거하여 잘 수행되고 있었으며 치료병실에 대한 오염관리에 대해서 대부분 병원에서 철저하게 수행하고 있는 것으로 나타났다. 결론 : 항목별 자료 수집내용을 충분히 검토하여 현실성 있는 설문조사를 통해 구체적인 표준안이 제시되었어야 하나 그러지 못한 부족함이 많다. 그럼에도 불구하고 본 조사에 대해 임상의 활용도 가치를 응답자 중 70.9%로 비교적 높이 평가해 주심에 감사를 표한다. 향후 본 자료를 토대로 각 항목별 세부사항에 대한 조사와 연구가 필요할 것으로 본다.

  • PDF

시약 변경 시 모집단 분포 추이에 따른 결과 분석 (Result Analysis according to Population Distribution Trends when Reagents are Changed)

  • 박혜미;임수연;유선희;이선호
    • 핵의학기술
    • /
    • 제27권1호
    • /
    • pp.55-61
    • /
    • 2023
  • Purpose In this study, the monthly population distribution was calculated for statistical verification of 10 tests (CA19-9, CA15-3, testosterone, PTH, calcitonin, AFP, CEA, CA72-4, PSA, estradiol) with changed reagents, and the trend of change By comparing and analyzing the results, we want to verify the accuracy of the results and improve the reliability of the test. Materials and Methods From June 2021 to February 2023, for the 10 items in which the reagent was changed, the monthly percentage and standard deviation index before and after the reagent change were compared, respectively. At this time, the reference value was arbitrarily set for the comparison group in consideration of the reference value of the test item, and the groups were subdivided and compared, and the standard deviation index allowed range was -2.0 or more and 2.0 or less. Results For CA19-9, CA15-3, AFP, CEA, and calcitonin 5 test items, the change in monthly ratio in all test sections before and after the reagent change was kept constant. On the other hand, for CA72-4, PSA, testosterone, PTH, and estradiol items, the standard deviation index exceeded the acceptable standard after changing the reagent. CA72-4 test items showed an increasing trend in standard deviation index in the test section exceeding the reference value. In the case of the PSA test item, the maintenance ratio of 0.04 ng/mL was significantly decreased after changing the reagent. The testosterone test item had a standard deviation index of -2.5 in the test section exceeding 10.1 ng/mL after changing the reagent, and the standard deviation index of the PTH test item was out of the acceptable range in all test sections. It was confirmed that the estradiol test item showed an overall increase in the result value. Conclusion Through this study, the continuity and accuracy of the test results could be verified. It is considered that the stability of the test can be secured by analyzing the factors affecting the test result and solving the cause for the test item whose standard deviation index is out of the acceptable standard.

  • PDF

PET-CT Normalization, Well Counter Correction에 따른 팬텀을 이용한 영상 평가 (Evaluation of Image for Phantom according to Normalization, Well Counter Correction in PET-CT)

  • 이충운;유연욱;문종운;김윤철
    • 핵의학기술
    • /
    • 제27권1호
    • /
    • pp.47-54
    • /
    • 2023
  • Purpose PET-CT imaging require an appropriate quality assurance system to achieve high efficiency and reliability. Quality control is essential for improving the quality of care and patient safety. Currently, there are performance evaluation methods of UN2-1994 and UN2-2001 proposed by NEMA and IEC for PET-CT image evaluation. In this study, we compare phantom images with the same experiments before and after PET-CT 3D normalization and well counter correction and evaluate the usefulness of quality control. Materials and methods Discovery 690 (General Electric Healthcare, USA) PET-CT equiptment was used to perform 3D normalization and well counter correction as recommended by GE Healthcare. Based on the recovery coefficients for the six spheres of the NEMA IEC Body Phantom recommended by the EARL. 20kBq/㎖ of 18F was injected into the sphere of the phantom and 2kBq/㎖ of 18F was injected into the body of phantom. PET-CT scan was performed with a radioacitivity ratio of 10:1. Images were reconstructed by appliying TOF+PSF+TOF, OSEM+PSF, OSEM and Gaussian filter 4.0, 4.5, 5.0, 5.5, 6.0, 6,5 mm with matrix size 128×128, slice thickness 3.75 mm, iteration 2, subset 16 conditions. The PET image was attenuation corrected using the CT images and analyzed using software program AW 4.7 (General Electric Healthcare, USA). The ROI was set to fit 6 spheres in the CT image, RC (Recovery Coefficient) was measured after fusion of PET and CT. Statistical analysis was performed wilcoxon signed rank test using R. Results Overall, after the quality control items were performed, the recovery coefficient of the phantom image increased and measured. Recovery coefficient according to the image reconstruction increased in the order TOF+PSF, TOF, OSEM+PSF, before and after quality control, RCmax increased by OSEM 0.13, OSEM+PSF 0.16, TOF 0.16, TOF+PSF 0.15 and RCmean increased by OSEM 0.09, OSEM+PSF 0.09, TOF 0.106, TOF+PSF 0.10. Both groups showed a statistically significant difference in Wilcoxon signed rank test results (P value<0.001). Conclusion PET-CT system require quality assurance to achieve high efficiency and reliability. Standardized intervals and procedures should be followed for quality control. We hope that this study will be a good opportunity to think about the importance of quality control in PET-CT

  • PDF

핵의학 영상에서 계수기반 체적변화 추적에 관한 고찰 (A Study on the Tracking of Count-Based Volumetric Changes in Nuclear Medicine Imaging)

  • 김지현;이주영;박훈희
    • 핵의학기술
    • /
    • 제28권1호
    • /
    • pp.57-69
    • /
    • 2024
  • Purpose: Quantitative analysis through count measurement in nuclear medicine planar images is limited by analysis techniques that are useful for obtaining various clinical information or by organ overlap or artifacts in actual clinical practice. On the other hand, the use of SPECT tomography images is quantitative analysis using volume rather than planar, which is not only free from problems such as projection overlap, but also has excellent quantitative accuracy. In the use of developing SPECT quantitative analysis technology, this study aims to compare the accuracy of quantitative analysis between ROI of the conventional planar images and VOI of the SPECT tomographic images in evaluating the count change happened by the volume change of the source. Materials and Methods: A 99mTcO4- source(200.17 MBq) was filled with sterilized water in the syringe to create a phantom with an inner diameter volume of 60 cc, and a planar image and a SPECT image were obtained by reducing the volume by 15 cc (25%) respectively. ROI and VOI(threshold: 1~45%, 5% interval) were set for each image obtained to estimate true count and measure the total count, and compared with the preseted volumetric change rate(%). Results: When volume changes of 25%, 50%, and 75% occurred in the initial volume of 60 cc(100%) of the phantom, the average count changes of the measured planar image were 26.8%, 53.2%, 77.5%, and the average count changes of the SPECT image were 24.4%, 50.9%, and 76.8%. In this case, the VOI size(cm3) set showed an average change rate of 25.4%, 51.1%, and 76.6%. The highest threshold value for the accuracy of radioactive concentration by VOI size (average error -1.03%) was 35%, and the VOI size of the same threshold had an error of -17.1% on average compared to the actual volume. Conclusion: On average, the count-based volumetric change rate in nuclear medicine images was able to track changes more accurately using VOI than ROI, but there was no significant difference with relatively similar value. However, the accuracy of radioactive concentration according to individual VOI sizes did not match, but it is considered that a relatively accurate quantitative analysis can be expected when the size of VOI is set smaller than the actual volume.

갑상선(甲狀腺) 기능항진증(機能亢進症)에서의 경구적(經口的) 당부하시험시(糖負荷試驗時) 혈장(血漿) Insulin의 변동(變動) (Radioimmunoassay of Plasma Insulin during Oral Glucose Tolerance Test in Thyrotoxicosis)

  • 이홍규;고창순;이문호
    • 대한핵의학회지
    • /
    • 제5권1호
    • /
    • pp.65-70
    • /
    • 1971
  • Blood glucose and immunoreactive insulin (IRI) were measured during oral glucose tolerance test in 15 thyrotoxic patients and 8 normal controls, to study the glucose metabolism in thyrotoxicosis. Following were the results; 1. In thyrotoxicosis, there is noticed late rise and late fall of plasma IRI durnig oral glucose tolerance test, like as phenomenon of mild diabetes mellitus. 2. When the thyrotoxic patients were divided into normal and abnormal responsive groups after the level of blood glucose by Wilkerson Criteria, no significant differences in plasma IRI levels were noticed between two groups. 3. This result may be interpreted as relative deficiency of insulin secretion from panceas and suggest genetically related defects.

  • PDF

만성골수성(慢性骨髓性) 백혈병(白血病)의 Ferrokinetics (Ferrokinetics on Chronic Myelogenous Leukemia)

  • 황기석;정창근;이재창
    • 대한핵의학회지
    • /
    • 제1권2호
    • /
    • pp.35-39
    • /
    • 1967
  • Ferrokinetcs by Pollycove's method on 2 cases of Chronic myelogenous leukemia were presented in order to study the erythropoietic function and pathogenesis of anemia. The results are as follows. (1) The daily hemoglobin syntheses were slightly elevated. Both the mean effective hemoglobinization time and mean erythron life span were shortened. The maximum net ROC incorporations of $^{59}Fe$ weere decreased. The in vivo surface measurements of radioactivity over liver, spleen, and sacral bone marrow revealed findings consistant with hemolysis and extramedullary hematopoies. (2) Based upon those findings it is assumed that anemia in chronic myelogenous leukemia may result from hemolysis and inadequate compensation to the developing anemia.

  • PDF

Metabolic Stability of [18F]Fluoroalkylbiphenyls

  • Lee, Kyo-Chul;Lee, Sang-Yoon;Choe, Yearn-Seong;Chi, Dae-Yoon
    • Bulletin of the Korean Chemical Society
    • /
    • 제25권8호
    • /
    • pp.1225-1230
    • /
    • 2004
  • The stability of fluoroalkyl groups as a pendent on the phenyl ring was measured in vitro using rat hepatic microsomes and human serum to predict their in vivo stabilities. We have prepared three [$^{18}F$]fluoroalkyl-biphenyls as the model compounds of fluoroalkyl aromatic compounds to compare the in vitro stabilities. In addition, in vitro stabilities were measured separately using rat hepatic microsomes and human serum at $37^{\circ}C$. Fluoroethylbiphenyl had similar or slightly superior stability to fluoropropylbiphenyl and these two compounds were much more stable than fluoromethylbiphenyl in vitro.